Figure 3.
MDRO transmission as assessed by combined genomics and epidemiologic assessment.
A/ Likelihood of transmission using combined genomic and epidemiologic data, by species. ‘Other’ (grey) includes patients with samples with no genomic links to other study samples (singleton STs, or above SNP screening thresholds). B. Putative transmission rates per 100,000 occupied bed days (OBDs) by species, coloured by hospital network. Horizontal dotted line represents the mean transmission rate for each species across all hospital networks. MRSA, methicillin-resistant Staphylococcus aureus; VREfm, vancomycin-resistant Enterococcus faecium; ESBL-Kp, extended-spectrum beta-lactamase-phenotype Klebsiella pneumoniae; ESBL-Ec, extended-spectrum beta-lactamase-phenotype Escherichia coli.